Tuberculosis vaccine: Phase IIb ongoing

The Oxford-Emergent Tuberculosis Consortium Ltd., a JV between Emergent and University of Oxford (Oxford, U.K.), completed vaccinations of 2,784 infants 4-6 months of age who received Bacille Calmette...